> What kind of growths? I get something like small scabs on skin on one
> part of my head
> under hair, don't know what they look like, but can be scratched off
> and regrow - this is
> only in winter. Less over the past few years.
> I've always thought that this is some kind of detox, since this
> happened after I started
> the paleolithic diet.
>
> The best (and only AFAIK) stuff to be rid of viruses (and germs) is
> *pure* oil of wild
> oregano - took 2 drops on tongue years ago, I went from a weak
> cripple one day to
> Superman the next.
>
> William
>
>
>
> --- In [hidden email], Andrew McAfee <amcafeerr@...> wrote:
>>
>> I have some growths on my head as well as some symptoms of a "stealth
>> virus" as described by Dr. John Martin.
>> I am hosting him in July with some other speakers to talk about
>> Vaccine
>> Illnesses.
>>
>> I find it very interesting just how many diseases are caused by these
>> types of virus found in vaccines.
>> Andrew
>>
>> 6 or so articles found here:
>> http://www.whale.to/vaccines/martin.html
>>
>>  
>>
>> NATIONAL VACCINE INFORMATION CENTER
>>
>> The Human Stealth Virus and Its Animal Origin
>>
>> THE VACCINE REACTION
>>
>> "When it happens to you or your child, the risks are 100%"
>>
>> Vol.1, No.4, Sept./Oct. 1995, Barbara Loe Fisher, Editor
>>
>> Published bimonthly by the National Vaccine Information Center
>>
>>  
>>
>> To The Reader: Since the beginning of September, I have been engaged
>> in
>> a remarkable dialogue with a scientist at the University of Southern
>> California whose work I became aware of after reading an article
>> published in the Riverside Press on August 28. Although the content of
>> the September October issue of The Vaccine Reaction had already been
>> scheduled, I came to the conclusion that this story was of such
>> importance and potentially impacts upon so many individuals suffering
>> from unexplained neurological, psychiatric and autoimmune disorder
>> symptoms, that the entire issue should be devoted to covering it. I do
>> not believe the significance of this research should be underestimated
>> or minimized and, in the interest of public health and safety, expect
>> that the Food and Drug Administration and Centers for Disease Control
>> officials responsible for insuring the public health and safety will
>> take their responsibilities seriously and act quickly to support
>> continuation of this research to confirm or disprove these scientific
>> findings. Failure to act now could jeopardize the health and well
>> being
>> of every baby born and every child and adult who may already be
>> infected with an atypical cytopathic virus they contracted through
>> exposure to contaminated vaccines or exposure to infected blood or
>> body
>> fluids. - The Editor
>>
>> DISCOVERY OF AN ATYPICAL VIRUS INFECTING HUMANS LINKED TO VIRAL
>> VACCINES PRODUCED ON MONKEY TISSUES
>>
>>  
>>
>> In what could be one of the most important scientific discoveries of
>> this decade, an award winning pathologist and immunologist at the
>> University of Southern California, W. John Martin, M.D., Ph.D., has
>> discovered an atypical virus infecting both children and adults who
>> are
>> exhibiting neurological, psychiatric and autoimmune disorder symptoms
>> with diagnoses including chronic fatigue syndrome, fibromyalgia,
>> depression, schizophrenia, anxiety disorder, seizures, developmental
>> delays, autism, lupus, multiple sclerosis, Alzheimer's, Parkinson's,
>> unexplained encephalopathy and chronic vegetative states. Martin and
>> his colleagues at USC's Infectious Diseases and Molecular Pathology
>> Laboratories have been meticulously culturing out stealth viruses from
>> patients for the past eight years and, in a stunning development
>> earlier this year, successfully identified one of the viruses as being
>> of African green monkey origin by using DNA sequence analysis. Kidney
>> tissues from African green monkeys have been used to make the live
>> oral
>> polio vaccine (OPV) as well as other viral vaccines during the past
>> three decades.
>>
>> YOU CAN BE INFECTED AND NOT BE SICK
>>
>>  
>>
>> A distinctive feature of the virus Martin and his colleagues has
>> characterized is that it belongs to a novel class of atypical
>> cytopathic viruses (capable of causing pathologic changes in cells),
>> which they refer to as "stealth viruses" because they have the ability
>> to evade detection by the body's cellular defense mechanisms and
>> appear
>> to lack the antigens which normally cause an inflammation typical of
>> most infections that damage cells and body tissues. The monkey-related
>> stealth virus they are studying is a cytomegalovirus belonging to the
>> herpes virus family that causes an atypical viral infection of the
>> brain - a "stealth virus encephalopathy" - that can produce a spectrum
>> of disease symptoms without evoking an inflammatory response.
>>
>>  
>>
>> Therefore, a person can also become infected and can carry and
>> transmit
>> the virus to others without exhibiting symptoms. The stealth virus can
>> remain dormant in an infected but symptomless individual throughout
>> life. However, in some infected individuals the virus can become
>> active, triggered perhaps by significant mental or physical stress,
>> and
>> go on to cause atypical responses to normal sensory input into the
>> brain resulting in sudden, unexplained neurological symptoms. It is
>> thought that a stealth virus can be transmitted, like HIV, hepatitis B
>> or polio, by coming into direct contact with the virus (such as
>> ingesting or being injected with a contaminated vaccine) or coming
>> into
>> contact with the blood or body fluids of an infected individual.
>>
>> CHRONIC FATIGUE SYNDROME, DEPRESSION, ENCEPHALOPATHY
>>
>>  
>>
>> In an August 1994 article published in American Journal of Pathologv.
>> Dr. Martin and his colleagues describe how over a three year period
>> they repeatedly cultured out an atypical cytopathic virus from a
>> 43-year old woman who became suddenly ill in 1990 with a sore throat,
>> muscle aches, intense headaches, fever and eventually was hospitalized
>> with suspected encephalitis/meningitis - although all tests came back
>> negative. She continued to feel ill and eventually was diagnosed with
>> chronic fatigue syndrome accompanied by severe headaches, insomnia,
>> memory loss and brain dysfunction. In that same article, Martin et al
>> confirm that they also cultured out the same atypical virus from a
>> patient with severe encephalopathy who had a four year history of
>> manic
>> depression.
>>
>> UNSTABLE VIRUS MUTATES EASILY
>>
>>  
>>
>> Several months later in an October 1994 article published in the
>> College of American Pathologists magazine CAP Today, Dr. Martin
>> explained that "stealth viruses have been derived from herpes viruses
>> (and possibly other viruses) by a process of major gene deletions and
>> mutations. These genetic changes presumably account for the lack of an
>> appreciable inflammatory response and for the wide host range of
>> infectable cells." Although he acknowledges that neurological,
>> psychiatric and immune system disorder symptoms can have a variety of
>> causes, just as stealth viruses present in animals and humans can have
>> different origins, Martin is pursuing the particular stealth virus he
>> has identified because he has been able to scientifically prove its
>> genetic relationship to African green monkey cytomegalovirus.
>>
>>  
>>
>> "The animal stealth virus we have identified has an unstable genome
>> and
>> it mutates easily. It doesn't grow very well in culture and so it can
>> be easily overlooked during testing. Of concern is the fact that, when
>> you introduce unstable animal stealth viruses into man, there is a
>> risk
>> of recombinant (the formation of new combinations of linked genes)
>> events occurring which can produce new kinds of diseases. Now that we
>> have the technology, it is very important to act immediately to screen
>> viral vaccines for stealth viruses, to determine who is already
>> infected and to develop therapies to interrupt activation as well as
>> treat those who already have symptoms."
>>
>> UNEXPLAINED SEIZURES, DEVELOPMENTAL DELAYS, MS, LUPUS,
> SCHIZOPHRENIA
>>
>>  
>>
>> In the CAP Today article, Dr. Martin reports on several cases
>> including
>> a 19 year old boy who had suffered unexplained severe brain damage at
>> age 17 and a six month old infant with unexplained seizures and
>> delayed
>> neurological development. Both patients had tested negative for brain
>> inflammation but tested positive for stealth virus infection. In
>> another case Martin describes several more patients who tested
>> positive
>> for stealth virus infection such as the woman who had been diagnosed
>> by
>> various doctors as having multiple sclerosis, lupus and cerebral
>> pseudotumor and a woman who was diagnosed as schizophrenic at age 19,
>> then manic depressive with delusions. Four years later she experienced
>> a near-fatal encephalopathy with cardiac arrest and has remained in a
>> vegetative state for five years.
>>
>>  
>>
>> In one family being studied by Martin and his colleagues, four family
>> members have tested positive for stealth virus infection including a
>> husband and wife diagnosed with chronic fatigue syndrome, the wife's
>> mother diagnosed with atypical Parkinson's disease and a son diagnosed
>> with schizophrenia. All of these patients are now being diagnosed as
>> suffering from stealth virus encephalopathy.
>>
>> AUTISTIC CHILD INFECTED WITH STEALTH VIRUS
>>
>>  
>>
>> In a letter published in early 1995 in the Journal of Autism and
>> developmental Disorders, Dr. Martin described the case of a 10 year
>> old
>> boy who began exhibiting autistic behavior at age one, was diagnosed
>> as
>> classically autistic at age four and currently exhibits ritualistic
>> and
>> aggressive behavior that is so difficult to control that he has been
>> institutionalized. He has repeatedly tested positive for infection
>> with
>> the stealth virus and Martin concluded, "Repeated culturing a stealth
>> virus from an autistic patient does not establish that the virus is
>> responsible for the patient's illness. Symptoms of autism are,
>> however,
>> consistent with impaired neurosensory functions due to persistent
>> viral
>> infection and previous attempts to demonstrate viruses in such
>> patients
>> may have failed to detect stealth viruses."
>>
>> DNA SEQUENCING OF VIRUS LEADS TO MONKEY ORIGINS
>>
>>  
>>
>> In an article published in the July 1995 issue of Clinical and
>> Diagnostic Virology, Martin and his colleagues describe how they
>> conducted DNA and amino acid sequence comparisons showing that the
>> stealth virus isolated from a patient with chronic fatigue syndrome
>> (CFS) was "more closely related to the Colburn strain of simian
>> cytomegalovirus than to cytomegalovirus of either human or rhesus
>> monkey origin or to any other sequenced herpes virus." These
>> comparisons were confirmed using polymerase chain reaction (PCR). The
>> scientists concluded that "the findings implicate the African green
>> monkey as the probable source of the virus isolated from this CFS
>> patient." They go on to suggest that "the potential introduction of
>> pathogenic viral variants into humans through the use of African green
>> monkey-derived cell lines in live virus vaccine production should be
>> evaluated."
>>
>> ANlMALS GET SICK TOO
>>
>>  
>>
>> Martin and his colleagues have performed more than 1,000 cultures in
>> their eight-year study of the stealth virus and have found that not
>> only is there a clustering of culture positive findings in members Of
>> the same families but that there is also a pattern of unexplained
>> neurological illnesses in the pet dogs and cats of patients diagnosed
>> with chronic fatigue syndrome, indicating that the stealth virus may
>> also be capable of infecting and being carried by animals. Testing
>> this
>> hypothesis, the scientists have isolated the monkey-related stealth
>> virus from a culture-positive human patient and injected it into cats.
>> In an article to be published in the December issue of Pathobiology,
>> they report their remarkable findings of what happens to the cats
>> after
>> they have been infected with the Virus.
>>
>> THE MONEY HAS RUN OUT
>>
>>  
>>
>> A casualty of the budget cuts that are hitting California and other
>> localities across the country, the minimal funding that has helped
>> USC's Infectious Diseases and Molecular Pathology Lab conduct stealth
>> virus research has now been exhausted. The Lab has been forced to
>> drastically cut back on its research linking the proliferation of
>> atypical neurologic, psychiatric and immune system disorders in
>> children and adults to the detection of an atypical cytomegalovirus
>> whose genetic code is almost identical to that of a virus that is
>> commonly present in the kidney tissues of the African green monkey and
>> could have, therefore, been inadvertently transmitted to humans during
>> the production of the oral polio vaccine. Committed to continuing
>> their
>> research because they know their discovery has the potential to save
>> lives, Martin and his seven colleagues have continued to work without
>> pay for the past month in an effort to keep USC's lab open.
>>
>> AN APPEAL TO THE FDA
>>
>>  
>>
>> Dr. Martin, who is professor of pathology and director of USC's
>> Infectious Diseases and Molecular Pathology Lab, has received numerous
>> awards, scholarships and fellowships during his 30-year career as a
>> distinguished scientist at Harvard, University College in London,
>> University of Sydney in Australia, NIH, Food and Drug Administration,
>> and the National Cancer Institute. In June, Dr. Martin and S. Zaki
>> Salahuddin, Ph.D., Li Chang Zeng, M.D., Khalid Ahmed, M.T., Jing G.
>> Seward, M.D., John-Carl Olsen, Inderjit Singh Seehrai, M.D., and Mark
>> Nowicki, Ph.D., applied to the FDA for a 6-month grant to:
>>
>>  
>>
>> 1) Determine the prevalence of simian cytomegalovirus derived stealth
>> viral infection in humans;
>>
>>  
>>
>> They are proposing a simple, quick and cost-effective way to do that
>> by
>> performing serological, polymerase chain reaction (PCR) and viral
>> culture testing of blood and lymphocyte samples already stored in the
>> National Heart, Lung and Blood Institute at NIH which were obtained
>> during the federally funded Transfusion Safety Study (TSS) conducted
>> in
>> the 1 980's. The University of Southern California acted as the prime
>> contractor for the TSS, a study which was conducted because of the
>> fear
>> that blood products were contaminated with viruses, including HIV. The
>> goal of the Transfusion Safety Study was to try to determine the
>> prevalence of viral infections, including HIV, in well defined
>> populations in the U.S.
>>
>>  
>>
>> In addition to the proposal to test the TSS samples for stealth virus
>> infection, Martin has already obtained permission from the Los Angeles
>> County - University of Southern California Medical Center's
>> Institutional Review Board to test blood and fluid samples stored in
>> their archives if funding can be obtained to do it. The scientists
>> estimate that if they tested a total of 250 blood samples from both of
>> these sources, it would be adequate to make an initial scientific
>> determination of the scope of stealth virus presence in the U.S.
>> population.
>>
>>  
>>
>> 2) To screen monkey colonies used for the production of viral vaccines
>> for the presence of stealth viruses.
>>
>>  
>>
>> They are proposing that immediate steps be taken to stop using monkeys
>> that are infected with the stealth cytomegalovirus to make vaccines by
>> culturing blood from each monkey designated as a source of kidney
>> tissue for vaccine production including performing PCR and viral
>> cultures to test for the presence of stealth virus.
>>
>> ACT NOW TO SCREEN VACCINES AND BLOOD SUPPLY
>>
>>  
>>
>> Martin and his colleagues concluded their appeal to the FDA to give
>> them a six-month grant to fund their work with these words: FDA is
>> responsible for the safety of biological products including vaccines
>> and the Nation's blood supply. As described in the Appendix to this
>> proposal, stealth viruses have been associated with severe
>> neurological
>> illnesses. It is imperative that the issue of the potential prior
>> transfer of pathogenic stealth viruses into humans be addressed. This
>> proposal will provide much needed data to assess the overall
>> prevalence
>> of stealth viral infection and the proportion of these infections
>> attributed to a cytomegalovirus derived stealth virus of African green
>> monkey origin. The proposal is also an important step towards ensuring
>> that future vaccine lots are free of stealth viruses. The findings
>> will
>> also have bearing on the possible need to screen blood donors for the
>> presence of stealth viruses."
>>
>> THERAPIES ARE BEING DEVELOPED
>>
>>  
>>
>> A major goal of Martin's research is to not only identify individuals
>> who are infected but to develop antiviral therapies which can
>> interrupt
>> the activation of a stealth virus in infected but symptomless
>> individuals as well as help those who are already exhibiting mild to
>> severe symptoms. Martin maintains that stealth viruses, whether of
>> animal or human origin, may also play a role yet to be identified in
>> other illnesses such as arteriosclerosis, autoimmune thyroid disease,
>> gastrointestinal and kidney disease, infertility and cancer. He and
>> his
>> colleagues are working on isolating a genetically engineered component
>> of the stealth virus which an infected individual could take orally to
>> inhibit its activation and growth.
>>
>> NVIC WILL OPERATE REGISTRY AND SUPPORT NETWORK
>>
>>  
>>
>> In a continuing effort to collect information from parents of children
>> as well as adults who have been adversely affected by vaccines, the
>> National Vaccine Information Center will expand the scope of its 1
>> 4-year old vaccine reaction registry and begin collecting information
>> and providing referrals to those who are suffering from unexplained
>> neurological, psychiatric and autoimmune disorder symptoms that are
>> potentially related to stealth virus infection. Parents of children or
>> adults who are exhibiting symptoms such as those described in this
>> newsletter and who want to be included in NVIC's registry will be sent
>> a questionnaire to fill out. To register and obtain a questionnaire,
>> write to Vaccine Reaction Registry, NVIC, 512 W. Maple Ave., Suite
>> 206,
>> Vienna, VA 22180. Please include a $5 donation to cover processing and
>> data entry costs.
>>
>>  
>>
>> Once the questionnaire is returned, NVIC can offer assistance to
>> registrars on how they can follow-up and be tested for stealth virus
>> infection and, additionally, determine whether they should or would
>> like to consider becoming part of the stealth virus research
>> laboratory
>> test database being developed by the USC lab.
>>
>>  
>>
>> NVIC is also expanding its 14-year old support network to help stealth
>> virus positive individuals to communicate with each other to exchange
>> information as well as become active in the promotion of research to
>> develop therapies and prevent infection.
>>
>> Reprinted in Issue No. 87 of the Leading Edge International Research
>> Journal
>>
>> Leading Edge Research Group, P.O. Box 7530, Yelm, Washington 98597 USA
>> - E-Mail: trufax@...
>>
>>
>> On May 24, 2007, at 1:25 PM, Marc Martin wrote:
>>
>>>> I was wondering if anyone would share if they've seen psychologists
>>>> about
>>>> their eSens issues and if they were any help, and if anyone has
>>>> tried
>>>> antidepressants like lexapro and other drugs and what effect they
>>>> had
>>>> on
>>>> their senstivities.
>>>
>>> Early on in my ES (7 years ago), I found that taking antibiotics
>>> eliminated my ES, but these were causing other problems and
>>> certainly were not something that I wanted to be taking
>>> forever. And they were only a temporary solution, as soon
>>> as I stopped taking them, my ES came back.
>>>
>>> The fact that antibiotics helped at all is rather interesting
>>> though, and leads me to wonder what the mechanism of action was.
>>> I can only think of two possibilities:
>>>
>>> * my ES is caused by some sort of chronic infection.
>>> * my ES is caused by excessive mobilization of toxins,
>>> and the antibiotics interferred with this.
>>>
>>> But I agree that going to a psychologist is probably useless.
>>> This is a physical condition, not a mental one.
>>>
>>> Marc
>>>
>>>
>>>
>>> Yahoo! Groups Links
>>>
>>>
>>>
>>>
>>
>
>
>
>
>
> Yahoo! Groups Links
>
>
>
>